NCT03698916 is a clinical trial of Celecoxib cream 8% in Osteoarthritis, Knee, sponsored by Credit Valley Rheumatology.

Who is sponsoring NCT03698916?

NCT03698916 is sponsored by Credit Valley Rheumatology.

What drugs are being tested in NCT03698916?

Interventions in NCT03698916: Celecoxib cream 8%.

What condition does NCT03698916 study?

NCT03698916 studies Osteoarthritis, Knee.

Is NCT03698916 still recruiting?

NCT03698916 is currently terminated. Last updated 3 May 2019.

Last reviewed 2019-05-03 · How we verify

NCT03698916

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delivra-Celecoxib 8% Cream and Osteoarthritis

Terminated Last updated 3 May 2019

What this trial tests

trial testing Celecoxib cream 8% in Osteoarthritis, Knee in 6 participants. Terminated before completion.

Timeline

23 July 2018

Primary endpoint
2 May 2019

2 May 2019

Quick facts

Lead sponsor	Credit Valley Rheumatology
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	6
Start date	23 July 2018
Primary completion	2 May 2019
Estimated completion	2 May 2019
Sites	3 locations across Canada

Drugs / interventions tested

Celecoxib cream 8% — full drug profile →

Conditions studied

Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →

Sponsor

Credit Valley Rheumatology — full company profile →

Who can join

Adults 30 to 75, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observation of the current use of a transdermal preparation of Celecoxib 8% which is being used in the treatment of patients with primary OA of the knees. Subjects will be followed for 12 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03698916 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Credit Valley Rheumatology
Last refreshed: 3 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03698916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing